EXPONENT INC (EXPO)

US30214U1025 - Common Stock

95.18  -0.26 (-0.27%)

After market: 95.18 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXPO. EXPO was compared to 82 industry peers in the Professional Services industry. EXPO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EXPO is valued expensive and it does not seem to be growing.



8

1. Profitability

1.1 Basic Checks

In the past year EXPO was profitable.
EXPO had a positive operating cash flow in the past year.
In the past 5 years EXPO has always been profitable.
EXPO had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

EXPO has a Return On Assets of 16.09%. This is amongst the best in the industry. EXPO outperforms 96.30% of its industry peers.
EXPO's Return On Equity of 27.06% is amongst the best of the industry. EXPO outperforms 85.19% of its industry peers.
The Return On Invested Capital of EXPO (16.57%) is better than 83.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXPO is significantly above the industry average of 11.79%.
Industry RankSector Rank
ROA 16.09%
ROE 27.06%
ROIC 16.57%
ROA(3y)15.92%
ROA(5y)15.33%
ROE(3y)28.11%
ROE(5y)26.15%
ROIC(3y)19.26%
ROIC(5y)17.2%

1.3 Margins

EXPO has a better Profit Margin (18.71%) than 88.89% of its industry peers.
In the last couple of years the Profit Margin of EXPO has remained more or less at the same level.
Looking at the Operating Margin, with a value of 20.86%, EXPO belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
EXPO's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 93.43%, EXPO belongs to the best of the industry, outperforming 97.53% of the companies in the same industry.
In the last couple of years the Gross Margin of EXPO has remained more or less at the same level.
Industry RankSector Rank
OM 20.86%
PM (TTM) 18.71%
GM 93.43%
OM growth 3Y-0.11%
OM growth 5Y-2.97%
PM growth 3Y-3.27%
PM growth 5Y-0.38%
GM growth 3Y-0.71%
GM growth 5Y-0.17%

10

2. Health

2.1 Basic Checks

EXPO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EXPO has about the same amount of shares outstanding.
The number of shares outstanding for EXPO has been reduced compared to 5 years ago.
EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 14.56 indicates that EXPO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 14.56, EXPO belongs to the top of the industry, outperforming 98.77% of the companies in the same industry.
EXPO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.56
ROIC/WACC1.83
WACC9.06%

2.3 Liquidity

A Current Ratio of 3.09 indicates that EXPO has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.09, EXPO belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
A Quick Ratio of 3.09 indicates that EXPO has no problem at all paying its short term obligations.
EXPO has a Quick ratio of 3.09. This is amongst the best in the industry. EXPO outperforms 92.59% of its industry peers.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 3.09

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.02% over the past year.
EXPO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.87% yearly.
Looking at the last year, EXPO shows a small growth in Revenue. The Revenue has grown by 3.07% in the last year.
The Revenue has been growing slightly by 7.18% on average over the past years.
EPS 1Y (TTM)1.02%
EPS 3Y7.95%
EPS 5Y7.87%
EPS growth Q2Q5.36%
Revenue 1Y (TTM)3.07%
Revenue growth 3Y10.31%
Revenue growth 5Y7.18%
Revenue growth Q2Q6.61%

3.2 Future

Based on estimates for the next years, EXPO will show a small growth in Earnings Per Share. The EPS will grow by 3.67% on average per year.
Based on estimates for the next years, EXPO will show a small growth in Revenue. The Revenue will grow by 3.18% on average per year.
EPS Next Y-6.37%
EPS Next 2Y1.17%
EPS Next 3Y3.67%
EPS Next 5YN/A
Revenue Next Year-2.99%
Revenue Next 2Y1.65%
Revenue Next 3Y3.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 48.07, which means the current valuation is very expensive for EXPO.
EXPO's Price/Earnings ratio is a bit more expensive when compared to the industry. EXPO is more expensive than 75.31% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.60. EXPO is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 47.69, the valuation of EXPO can be described as expensive.
EXPO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. EXPO is more expensive than 71.60% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.15. EXPO is valued rather expensively when compared to this.
Industry RankSector Rank
PE 48.07
Fwd PE 47.69

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXPO is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
EXPO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 36.44
EV/EBITDA 38.1

4.3 Compensation for Growth

EXPO has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)6.11
EPS Next 2Y1.17%
EPS Next 3Y3.67%

5

5. Dividend

5.1 Amount

EXPO has a Yearly Dividend Yield of 1.17%.
EXPO's Dividend Yield is a higher than the industry average which is at 1.99.
With a Dividend Yield of 1.17, EXPO pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 1.17%

5.2 History

The dividend of EXPO is nicely growing with an annual growth rate of 28.64%!
EXPO has been paying a dividend for at least 10 years, so it has a reliable track record.
EXPO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)28.64%
Div Incr Years10
Div Non Decr Years10

5.3 Sustainability

EXPO pays out 54.43% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EXPO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.43%
EPS Next 2Y1.17%
EPS Next 3Y3.67%

EXPONENT INC

NASDAQ:EXPO (5/17/2024, 7:00:02 PM)

After market: 95.18 0 (0%)

95.18

-0.26 (-0.27%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.82B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.17%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 48.07
Fwd PE 47.69
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)6.11
Profitability
Industry RankSector Rank
ROA 16.09%
ROE 27.06%
ROCE
ROIC
ROICexc
ROICexgc
OM 20.86%
PM (TTM) 18.71%
GM 93.43%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.09
Quick Ratio 3.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1.02%
EPS 3Y7.95%
EPS 5Y
EPS growth Q2Q
EPS Next Y-6.37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.07%
Revenue growth 3Y10.31%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y